Anshul Maheshwari has filed a Form 144 to sell 3,738 shares of SI-BONE, Inc. This sale is valued at approximately $81,600. The transaction is part of Maheshwari's ongoing stock sales under a pre-arranged trading plan.

This filing is significant as it reflects Maheshwari's strategy to manage his equity position in SI-BONE, a company that operates in the surgical and medical instruments industry.

Background

Maheshwari Anshul is an officer at SI-BONE, Inc., which is classified under the SIC code for surgical and medical instruments and apparatus. The company has been active in the market, with recent filings indicating ongoing transactions involving its securities. SI-BONE, Inc. is listed on NASDAQ with the CIK number 0001459839.

What the Filing Says

According to the filing, Maheshwari plans to sell 3,738 shares of common stock acquired through restricted stock units that vested between April 1, 2026, and October 1, 2026. The filing notes, "The securities to be sold were acquired upon the vesting of restricted stock units during the period of 04/01/2026 through 10/01/2026."

Impact

This sale may affect other shareholders and investors in SI-BONE, Inc., as it indicates the company's executives are actively managing their stock holdings. Such actions can influence market perceptions and investor confidence in the company.

What's Next

The filing does not say what happens next regarding additional sales or future plans for Maheshwari's equity in SI-BONE.